Trial intelligence / Profile preview

STARA: Stopping TNF Inhibitors in Rheumatoid Arthritis

NCT01793519Phase 4Active, not recruiting

Sponsor
Georgetown University
Start
Jan 2013
Primary completion
Jun 2024
Modality
Monoclonal Antibodies, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 4 trial of etanercept, infliximab, adalimumab in rheumatoid arthritis (RA), sponsored by Georgetown University. Started Jan 2013; status: active, not recruiting.

02

Drugs

etanerceptinfliximabadalimumab
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT01793519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01793519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call